SBIR/STTR Research Award
TOPIC 343: NEUROPSYCHOLOGICAL ASSESSMENT SYSTEM FOR CANCER PATIENTS
Award amount
$1,499,588Program and phase
SBIR · Phase IIAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CREARE LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- JDKYAKDT4TT6
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
Cognitive decline is a major quality of life concern for many cancer survivorsThevarious available treatments affect individuals differentlyand research has unfortunately provided little guidance on how specific treatments impact neurocognitive functionTo help researchers fill this information gap and ultimately provide guidance to doctors and patientsa neuropsychological assessment system that is designed specifically for repeated assessment of cancer patients and survivors is needed Creare will develop the Neuropsychological Assessment System for Cancer Patients NASCPa mobileself administeredrepeatable neuropsychological assessment system specific to cancer patients and survivors comprising of a mobile appa secure HIPAA compliant serverand a web portal for researchers and cliniciansThe components of the NASCP will be assessed in a human study
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Improving Signal-to-Noise in Military Boom-Mounted Microphones
- A Defect and Damage Inspection Tool for Incoming Part Inspection
- Data Processing and Analysis Framework for Infrastructure Planning to Promote Active Transport
- Portable Hydrogen Filling System for Expeditionary Advanced Bases
- Low-Cost Closed-Loop Cryogenic Cooler for High Power Optics
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
1,365 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $507,020,394. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, Department of Transportation, Department of Commerce